BioCentury
ARTICLE | Company News

m-phasys signs Bayer deal

July 10, 2001 7:00 AM UTC

In a two-year deal, m-phasys (Tubingen, Germany) will identify compounds acting on membrane protein targets for Bayer (FSE:BAYG). Using its M-Fold technology, m-phasys will produce the membrane protei...